Advantages of venous bypass during orthotopic transplantation of the liver. by Shaw, BW et al.
SEMINARS IN UVEa DISEASE-VOL. 5. NO.4. 1915 
Advantages of Venous Bypass During. 
Orthotopic Transplantation of the Uver 
BYERS W. SHAW Jr., M.D., DOUGLAS J. MARTIN, M.D., 
JOSE M. MARQUEZ, M.D., Y. G. KANG,M.D., 
ALAN C. BUGBEE Jr., Ph.D., SHUNZABURO IWATSUKI, M.D., 
BARnEY P. GRIFFITH, M.D., ROBERT L. HARDESTY, M.D., 
HENRY q~ BAHNSON, M.D., and THOMAS E. STARZL, M.D., Ph.D. 
The anhepatic phase of an orthotopic: liver 
transplantation procedure occun when the surgeon 
has removed the native liver (along with the intra-
hepatic: portion of the vena cava) and is involved in 
sewing in the donor organ. During this interval. the 
inferior vena cava is c:ross-clamped at the 
diaphragm and at a point just above the entry of 
the renal veins. The result is a complete interruption 
of venous return from the inferior vena cava. u is 
evident from a sudden decrease in both central 
venous and pulmonary arterial wedge pressures, 
resulting . in a profound reduction of cardiac: 
output. I 
The portal vein is also c:lamped. of necessity. 
during this phase. A sudden and marked inc:rase in 
hydrostatic: pressure in both the portal and systemic: 
venous beds thus occ:un. This not only causes 
damage to the kidneys, bowel. and pancreas. but 
also can profoundly exacerbate hemorrhage from 
the tissues that were cut during the recipient hepa-
tectomy. 
Early Approach .. to the Problem 
Early attempts at transplantation of the liver in 
dogs required the use of some means of relieving 
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pressure in the obstructed portal vein because dogs 
usually died 20 to 30 minutes after c:lamping the 
portal vein. To avoid this problem. Starzl routinely 
constructed an end-to-side anutomosis between the 
divided portal vein and the vena cava just below the 
liver. then bypassed flow from the lower vena cava 
to the superior vena cava (via the jugular vein) 
using passive shunts.2 
Similar shunts were used during the rust 
human trials of orthotopic: transplantation of the 
liver. However, pulmonary embolism played a 
major role in the deaths of three of the rust four 
patients in the Denver experience.3 The passive 
shunts were thought to be the major cause. 
In previous studies. Starzl's group bad also 
shown that dogs that were made cirrhotic: (by 
chronic: bile duct ligation) did not require shunting. I 
Apparently. adequate pOrtal decompression wu 
provided by the formation of spontaDeous shunts 
through c:ollaterals resulting from c:bronic: portal. 
hypertension. This finding led Starzl to attempt the 
next few c:linic:al transplants without the use- of 
shunts. Starzl', group subsequently found that. in 
,eneral, all humans. not· just those with portal 
hypertension, tolerated the anhepatic: phase much 
better than did dogs. 
From March 1. 1963, to Mardll980. the poup 
in Denver wu inyolved in the transplantation of the· liver in 170 patients using azathioprine and predni-
sone for immunosuppression. Other mcvl,Uticl. 
such u antilymphocyte serum or its a10bulin deriva-
tive and thoracic duct drainage, wae also used u 
adjuvant immunosuppression durina the latter part 
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of this period. Ahhoqb these drua reaimeas were 
able to provide more than 50tre I-year kidney paft 
survival, they prcmd UDSatisfactory for liver trans-
plantation.· Rejection remained the major source of 
morbidity aDd mortality. TecbDical improvements 
continued to be important durina this period, but 
ultimately, their capacity to improve patient lur-
vival was severely Mndicapped because of rejection. 
BeainniDa in March, 1980 cydosporine wu 
introduced in DenYa' as an immUDOSUppressant for " 
liver recipients. The subsequent improvement in sur-
vival rates wu dramatic. Althouah by no means 
elinUuted, rejection bad been ameliorated coDSider-
ably. AJ a rault, Starziand his II'OUp, now in Pitts-
bursh. rapidly cxpudcd their experience. By late 
Spring, 1982, 42 adults had received liver trans-
plants under cydosporine therapy. 
Amona this pvup of 42 adults, four (9.''1.) 
were considered operative deaths. In addition, the 
death of a number of other patients ultimately ap-
peared to be related to a difficult operative course. 
With I-year survival rates in adults bavina risen 
from 26'" to more than 60'" after the introduction 
of cyclosporine, morbidity and monality related to 
operative difficulties gained increasiq attention. 
A review of the causes of these operative 
failures revealed that many could be eliminated if 
the hemorrhage and cardiodynamic instabilities oc-
curring duriq the anhepatic phase could be 
avoided. With this goal in mind, the II'OUp in Pitts-
burgh, with the help of the cardiac surgeons under 
the direction of Dr. H.T. Bahnson, undertook a 
trial of venous bypass in the summer of 1982. This 
technique employed a conventional cardiopulmo-
nary bypass apparatus With a roDer head pump and 
cardiotomy reservoir. It required that the patient be 
given systemic anticoagulation. Heparin was chosen 
because it was a satisfactory anticoagulant for 
cardiac SUflery and it could be reversed readily with 
protamine. 
Between June 15 and September 6, 1982, 12 pa-
tients received transplants using this method of 
venous bypass. Nine were adults. Three of these 
nine patients died in the operating room: two from 
uncontrolled hemorrhage, the third of cardiac arrest 
during a retransplant procedure. Four of the re-
maining six patients died in less than 3 months. 
Only two obtained long-term survival. Mean opera-
tive blood loss in these patients was 53.1 ± 33.0 
(SD) units of packed red blood c:ells (PRBC), con-
siderably more than the blood losses experienced in 
previous cases without the use of bypass. The prob-
lems, for the most part, appeared related to the 
need for anticoqulation and the resultant exacerba-
tion of both preexisting coqulopatbies and the 
r •. 
"' 
fibrinolytic phase followina masc:ularizatioa of the 
hepatic a1loaraft. 
Despite these discourqiq results, the potential 
advantaaes that the system miaht offer were quite 
dear. The three children and aeveraI adults who did" 
not experience bleedina diutheses obtaiDecl marked 
stabilization of cardiodynamic parametm during 
the anbepatic phase. As if to underscore' the need 
for some form of bypass further, after this method 
was abandoned in September, two more adults died 
on the operatiq table while underloina transplan-
tation without bypass, laqely u the "rault of their 
inability to tolerate the severe hemodynamic insults 
of the anhepatic phase. With this expaieDce behind 
them, the II'OUp in Pittsburgh returned to the labor-
atory to develop a bypass Iystem that would not 
require anticoaaUlation of the recipient. 
Bypa .. Without Heparinization 
In the fall of 1982. the team in Pittsburgh 
began perfol1Ding liver transplants on dOlI using a 
closed circuit bypass apparatus that did not require 
that the animals be heparinized. The initial SUlles-
tion that this miaht prove successful came from one 
of the cardiac surgeons at the University of Pitts-
burgh Health Center, B.P. Griffith. The technique 
employed the same centrifu", force pump that the 
cardiac team had been using to pump blood 
through an extracorporeal memb1'1lDC oxygenator 
used to support infants for long periods of time. 
The pump offers the advantage of beina less trau-
matic to red blood cells and, because it can be 
safely used in a closed system, a reservoir is not 
required. 
The results of these experiments were presented 
previously.5 The success of the technique led to the 
initial clinical trials of the system in February 1983.6 
The subsequent use of this method of bypass during 
liver transplantation in 57 adult patients was the 
subject of another report.7 The substance of the 
latter article will be reviewed herein. 
MATERIALS AND METHODS 
A total of 129 adults were transplanted in Pitts-
burgh between March 9, 1980, and March 22, 1984. 
Of these, 63 were operated on without the use of 
bypass, nine with the heparinized system, and 57 
with the system that does Dot require anticoqula-
tion. Cardiopulmonary data were obtained on a 
subgroup of 28 patients who were studied prospec-
tively in the operatina room with multiple lumen, 
oximeter tipped, pulmonary artery catheters. 
\ 
Parametcn were recorded It prcdefmecl intervals 
durina the transplant procedure, and mean values 
were compared usiq the paired t test. These data 
were also compared in a less riaid fashion to data 
obtained previously in a Dumber of patients trans-
planted without bypass. 
Retrospective reaal functioD data were avail-
able on 38 and 49 patients in the DOnbypass and 
bypass &roups, respectively. The means of the 
preoperative and of the muimum. postoperative 
sauDI creatinine (duriq the fust 3 days after trans-
plantation) were c:ompared usina unpaired and 
paired t tests. The mean operative blood losses for 
43 and 36 patients, respectively. were also compared 
using unpaired t tests and the median values were'· 
compared with rank sum analysis. Finally. life-table 
survival curves were generated for each &rOUp 
(exclusive of the heparinized patients) and com-
pared using the staDdard error of the survival prob-
abilities for each interval. 
RESULTS 
Cardiodynamic Data 
The cardiodynamic profiles obtained are shown 
in Table 1. These show that both central venous 
and wedged pulmonary artery pressures were sus-
tained at levels equal to those measured just before 
placing the patient on bypass and completing the 
hepatectomy. During the period of bypass, the 
cardiac index decreased, but the arterial-venous 
oxygen content difference remained unchanged. 
reflecting adequate tissue oxygenation. Thus, the 
decrease in cardiac index was apparently an appro-
priate response to a measured decrease in body tem-
perature and removal of the liver. Using the Fick 
equation, a signiflCllllt decrease in oxygen 
CODSUmption was cak:ulated. 
These data are in contrast to those obtained in 
a previous study that reported a SO.,. to fivefold 
reduction in cardiac index during the anhepatic 
phase in those patients undergoing transplantation 
without the use of bypass. During bypass, flow 
rata through the system have ranged from 800 mV 
minute to more than '000 mVminute. representing 
anywhere from 25 to 7.5" of the measured cardiac 
output at the time. 
Re.'Function 
In those patieDts transplanted without bypass, 
the mean maximum serum creatinine within 3 days 
after transplantatiOD wu 3.0 rqldi. ThIs repre-
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TABLE 1. Cardlopulmonery 'rofl_1n 21 , ...... 
U ...... 01 .... v ........ "... WIthout AntIcaegulation 
~K"KK Bn-y..,.. 
""." so Aha SD pt 
TrQ 34.9 .91 33.1 1.16 O.oem 
HR(bpm) 1506 14.3 14.1 14.2 
MAP (1IIIIIHa) 7S 17.1 Il 11.6 
PAO(torr) 12.0 4.2 10.s 3.3 
CVP(zDmHa) 9.9 4.4 9.2 . 4.9 
pC02 (torr) 33.3 S.2 19.9 4.1 0.0125 
pOa (torr) 310 92.4 391 91.6 
SaOa 0.9154 0.0915 0.9196 0.01S» 
P¥Oa (torr) 65.5 16.3 10.' 21.5 
~aEtorrF 0.904 0.0591 o.m 0.0496 
Hb(JIdl) 9.62 1.16 10.2 1.42 
pHa 1.42 0.07 1.40 0.08 
CI(UtenI 4.31 1.44 3.44 1.09 0.0079 mia-mJ) 
SI 51.'7 1S.9 41.4 13.6 0.0121 
RVSWI 5.11 3.21 3.s2 3.11 
LVSWI 43.4 14.3 39.1 11.4 
SVR.I 443.1 233 6fiO 366 0.0109 
PV1U 34.3 23.9 44.1 39.1 
avD02 2.04 .11 1.11 .59 
V02/ma 13.0 24.1 61.1 20.5 0.0009 
O2 traDIpOrt 1017 391 911 342 
8'f: temperature; HIl: heart rate; MAP: maD arterial pressure; 
PAO: pulmoaary ancrlaI wedae prasun; CVP! central venous 
pressure; pC02! putiaI pressure of c:arboD diCDide; p02! partial 
preaure of OXJICD: Sa02! arterial Oxyaal lablratioa; PYOa! 
mbIed YeDOUI 0QJeIl preaure; Sv02! oxypn WDration pu1mo-
nary artery; Hb: 1aemoiIobia; pHa: ancrlaI pH; C1: c:arciad 
iDdelt; SI: saturation iDda; RVSWI: riabt veatric:ular stroke 
work iDdex; L VSWI: left YCDtric:uIar stroke work lDda; SV1U: 
systemic vucuJu raiItaDce iDda; PVRI: puImoauy vucuJu 
raistaDce inda; avD02! artericmDouJ oxypn content differ· 
ence; V02/mJ : OXJICD CODIUIIlplion. 
tPaired I test. 
sented a mean change of + 1.29 (± 1.9S) mg/dl. 
Six of these patients. who did not have overt renal 
failure preoperatively, required dialysis during the 
fIrst week after the liver transplant. In contrast, the 
maximum creatinine averaged I.' mg/d! in the by-
pass group, and nODe of these patients required 
dialysis after the liver transplant. 
Operative Blood Lon 
Bypass also had a dramatic effect on the mean 
operative blood 1051 for liver transplantation in 
adults. The mean Dumber of units of PUc. trans-
fused decreased from 33 ± 25 in the Donbypass 
IfDUP to 19 ± 8 (p<O.Ol) in the bypass group and 
the mediaD loss (perhaps a more iDdicative figure 
because of the tremendous standard deviation in the 
mean calculations) decreased from 27 to 16 units 
(pcO.05). 
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SurvlvelDa .. 
At 30 cia", the bypua II'OUp obtained a 91 .. 
survival venus 73 .. for the nonbypuaed &rOUP 
(p<O.OO4). However, at 90 da", this advantqe 
was no lolller statistically sipificant. To find the 
cause of this phenomenon, the overall p'oup of pa-
dents was broken down into cateaories, dependina 
upon preoperatift risk facton (see ICCOIDpanying 
artide by Shaw et at in this issue of &minlln). Pa-
dents were assiped to one of three status groups. 
Status 1 padents were low risk. status 2 were 
medium risk. and status 3 were hip-rilk padents. A 
padent couktbe plac:cd in the hiP-risk group for 
either physiolOlic or technical reasons. The latter 
were those padents who had had major surgery 
involvina the liver or bUe duels. such as portocaval 
shunt or muldple attempts at biliary reconstruction. 
or those with documented ponal vein thrombosis. 
Bypass improved 30-day survival in all three 
status groups. This advantage continued beyond 90 
days for both status I and status 2 patients. How-
ever. the higb-risk group who had undergone 
bypass and who had an early 301ft survival advan-
tage over nonbypassed patients (61.S'Io vmus 
31'10), suddenly experienced a marked increase in 
mortality between 30 and 90 days postoperatively, 
so that by the end of 6 months, survival was equi-
valent to the nonbypassed group. Of further note, 
the only long-term survivors in the status 3 bypass 
group were the two patients placed in that group by 
virtue of technical rather than pbysiologic reasons. 
In contrast, -three of the four tecbnic:a11y hip-risk 
patients in the nonbypass group died in the 
operating room and the fourth within 48 hours of 
surgery. 
FURTHER THOUGHTS ON 
VENOUS BYPASS 
In the IS months since the original report of 
the intraoperative, hemodynamic. and postoperative 
advantages that venous bypass offers patients 
undergoing orthotopic transplantation of the liver. 
the group in Pittsburgh has bad experience using 
the tec:hnique in well over 100 additional adult pa-
tients. Oearly, liver transplants can be ac:c:omplish-
ed in adults without this methodology. However, 
the technique has proved to be so suc:cessful and so 
easily done on a routine basis, that it becomes 
almost inconceivable that anyone should want to do 
so. For purposes of added safety and greater simpli-
fication, fuDy heparin-bonded, single-piece tubing 
c:irtuits arc now available commercially. Full 
J .;._: .... ,0 .. - . 
heparin coatina of the entire tublna dn:ult virtually 
elimiNtes the cbancc of dOlI formina in abe tubina 
should now throIiab the bypass need to I»e inter-
rupted for any I'CUOD durina 1bc bypus pbuc. 
Morbidity from the procedure bu beaa limited 
to the oc::cumnce of &roin or uiIlary seromu in ap-
proximately 25 .. of patients. The iDcideDce of these 
can be minimized by more careful dliRCtioll of the 
uiIIary or saphenous veins to avoid injmy to small 
lymphatics and by careful dosure of the wounds in 
layen •. 
On the other hand, one patient ha4 a massive 
and Immediately fatal pulmonary embolism lOOn 
after starting bypaa. This patient ha4 polycystic 
disease of the liver and the primary indication for 
transplantation was massive bepatomeaalY causinl 
SJlDptoms of inferior vena cava obstruc:don. In 
retrospect, this problem should be added to acute 
Budd-Cbiari syndrome as the two d __ for 
which venous bypaa is contraindicated. The risk of 
entrainina preexisting clot from the YeIIOUI beds 
and -then embolizing them centrally fu outweighs 
the advantaaes of the technique. 
A more subde but no less important advantage 
of bypass is the list of operative options that it 
offers to the surleon who employs it. All of these 
options arc based on the single fact that the bypass 
allows a longer anbepatic phase. During this period 
on bypass, bleeding is not constandy ac:celerating 
because of the rapid buildup of hydrostatic pressure 
in obstruc:ted venous beds. Patients with less 
resilient cardiac function no longer begin the 
alarmingly sudden deterioration in hemodynamic 
status that so often typified anhepatic phases 
without bypass lasting more than about 30 to 4S • 
minutes. This extra time and, more importantly, the 
knowledge that one will have this extra time if 
needed allows the surgeon to tailor the transplant 
procedure to the --individual patient. Thus, if he 
fmds that the recipient hepatectomy is particularly 
difficult and that meticulous dissection and careful 
hemostasis are not going to be possible, be has the 
option of halting the c:lissec:tion, pinial complete 
control of any-·bleeding points created up to that 
point, and then waitinl for -the arrival of the donor 
liver in the recipient operating room. Once the 
donor organ is ready for implantation, the surgeon 
can place the recipient on bypass, and then rapidly 
excise the liver. More than 1 hour can be spent with 
the liver removed and with full Yisualjption of the 
entire field, obtaining reasonable bemostasil. Thus, 
the bypass prevents the prolonged period of steady 
blood loss that might have resulted had the surgeon 
not had this option and persevered along the 
original tack. 
. . 
This is not to imply that the bypass allows for 
reckless abandon or that it is a IUbatitute for careful 
suqical technique. In fact. IDaDy IUfICODI may still 
prefer to carry out a c:arefuIly hemostatic dissection 
in any case that wiD allow it, which will be the over-
whelmina majority of cases. However, it does 
provide a certain dcpee of comfort to know not 
only that the patient is loina to be quit.e stable 
d1ll'iq that time when the inferior vena cava and 
the portal vein have been damped and transccted, 
but also that one can exen:ise one of several options 
for ac:complishiDa the native hepatectomy. 
Althouah no mention bas been made of the use 
of bypass for children, it has been used occasionally 
for children undeqoinl transplantation in Pitts-
burah. It is not used more often mainly for two 
reasons. First, children almost never need it. In most 
instances, they tolerate the anhepatic state much 
better than do adults. Secondly, the initial work in 
the laboratory raised lenuine concerns over the 
potential danlen of low rates of blood flow in 
plastic tubes without the use of anticoaauJants. 
The developmental laboratory work on 
heparinless bypass, reported by Denmark et aI,5 
revealed that when flow in the unheparinized system 
decreased below about 800 mllminute, platelet 
counts and fibrinosen levels decreased and fibrin 
split products bepn to accumulate. This suuested 
that coagulation was beins activated as the blood 
passed more slowly throuah the tubina. and 
althoush no emboli were apparent, this was taken 
as a waminl sian that a lower limit of flow should 
be set. AccordinsIy. when the system was flI'St used 
clinically, a lower limit of 1000 mllminute was used 
as the level of flow below which bypass would be 
terminated. The degree of caution attending the ap-
plication of something new like this for patients was 
understandably hiah.. As a further safety measure, 
the initial tubinl circuit used clinically wu partiaUy 
constructed of heparin-bonded plastic tubina. The 
Pittsburgh IfC)Up recendy reported that subsequent 
work in the laboratory and a limited experience 
clinically sugest that the safe lower limit of flow 
rate miaht be much 10wer.1 One must exercise con-
sidaable caution. however, siDee 2 of 40 dolS in 
this study died suddenly from pulmonary emboli 
while on low-flow bypass. These latest studies were 
done without the use of any heparin-bonded tubiDl. 
Other recent work in the laboratory indicate that a 
completely heparin-bonded tubina c:in:uit allows one 
to inten'Upt flow in the tubina completely for up-
ward of 15 to 20 minutes without dot formation. 
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Thus. safe bypas$ is possible in chDdren. even 
at· markedly reduced flow. However, the likely ratio 
of benefits to risb for most children will be low 
enouah to require a much more selective use of 
venous bypass. Those children with poor cardiac 
reserve or who appear unable to tolerate a test 
clampiq of the portal vein and vena cava are prob-
ably candidates for venous bypass. 
SUMMARY 
Venous bypass restores normal hemodyDamic 
physiolOlY durinl the critical anhepatic phase of 
orthotopic transplantation of the liver. Its routine 
use in adults undcraoinl transplantation in Pitts-
burah has resulted in lower operative blood losses, a 
lower frequency of postoperative renal failure, and 
a areater probability of survival for aU but· the 
hishest risk patients. Because it aUows for a 10Dler 
anhepatic phase, the SUfleon has the option of 
tailoring the native hepatectomy to the needs of the 
individual case, even to the point, in difficult cases, 
of obtainins most of the hemostasis after removal 
of the native liver, but before sewinl in the donor 
orpn. Selective use of bypass in children may offer 
similar advantqes. 
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